We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
All content for AI Uncovered is the property of Timothy Martin, Executive VP of Product at Yseop and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
Fred Schonenberg - The Vital Role of GenAI in Enterprises
AI Uncovered
37 minutes
1 year ago
Fred Schonenberg - The Vital Role of GenAI in Enterprises
We welcome Fred Schonenberg to AI Uncovered. Fred is the founder and CEO of VentureFuel. He has created an innovation framework that bridges the VC, Angel, and Startup ecosystem with enterprises to deliver tangible technology solutions that drive growth. In his role at Venture Fuel, Fred has worked with over 100 companies from General Mills to Netflix.He is a frequent speaker at industry events such as SXSW, Ad Tech, and Advertising Week and is published in broad media publications including ...
AI Uncovered
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
